Richard D Carvajal Selected Research

Richard D Carvajal Research Topics

Disease

77	Neoplasms (Cancer) 01/2024 - 12/2006
73	Melanoma (Melanoma, Malignant) 01/2024 - 04/2010
41	Uveal melanoma 12/2023 - 04/2011
14	Neoplasm Metastasis (Metastasis) 01/2023 - 10/2013
9	Disease Progression 02/2023 - 04/2014
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 06/2012
7	Fatigue 11/2022 - 01/2009
7	Sarcoma (Soft Tissue Sarcoma) 11/2022 - 05/2012
6	Fever (Fevers) 12/2023 - 01/2019
5	Nausea 01/2021 - 12/2009
4	Diarrhea 01/2021 - 01/2009
4	Neutropenia 04/2015 - 01/2009
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2024 - 06/2015
3	Exanthema (Rash) 12/2023 - 01/2018
3	COVID-19 01/2022 - 01/2021
3	Skin Neoplasms (Skin Cancer) 01/2021 - 01/2018
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2019 - 03/2012
2	Pruritus (Itching) 12/2023 - 01/2021
2	Injection Site Reaction 11/2022 - 08/2010
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2020
2	Vomiting 01/2021 - 12/2009
2	Carcinogenesis 06/2019 - 07/2012
2	Hypertension (High Blood Pressure) 08/2017 - 11/2015
2	Hypersensitivity (Allergy) 01/2017 - 08/2010
2	Brain Neoplasms (Brain Tumor) 07/2015 - 05/2015
2	Colorectal Neoplasms (Colorectal Cancer) 06/2012 - 11/2010
2	Hyponatremia 04/2011 - 12/2009
1	Mesothelioma 01/2024
1	Triple Negative Breast Neoplasms 01/2024
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 12/2023

Drug/Important Bio-Agent (IBA)

17	IpilimumabIBA 12/2023 - 04/2010
13	Proteins (Proteins, Gene)FDA Link 12/2023 - 04/2011
11	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 09/2011
11	Immune Checkpoint InhibitorsIBA 01/2022 - 04/2014
10	Monoclonal AntibodiesIBA 01/2021 - 04/2014
9	tebentafuspIBA 12/2023 - 07/2019
8	AZD 6244IBA 01/2018 - 07/2012
7	pembrolizumabIBA 12/2023 - 01/2016
7	Dacarbazine (DIC)FDA LinkGeneric 12/2023 - 06/2014
7	NivolumabIBA 02/2023 - 04/2014
6	Imatinib Mesylate (Gleevec)FDA Link 11/2022 - 05/2011
6	alvocidib (flavopiridol)IBA 11/2012 - 01/2009
5	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2023 - 07/2019
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2013
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2010
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2023 - 06/2015
4	Phosphotransferases (Kinase)IBA 01/2023 - 12/2006
4	AntibodiesIBA 11/2022 - 06/2013
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2022 - 06/2011
4	Mitogen-Activated Protein KinasesIBA 01/2022 - 10/2013
4	Protein Kinase CIBA 01/2022 - 10/2013
3	HLA-A Antigens (HLA-A)IBA 12/2023 - 01/2021
3	CytokinesIBA 10/2022 - 01/2021
3	sotrastaurinIBA 01/2022 - 01/2020
3	AntigensIBA 02/2021 - 06/2013
3	LigandsIBA 11/2019 - 06/2012
3	Docetaxel (Taxotere)FDA Link 11/2015 - 01/2009
3	B7-H1 AntigenIBA 03/2015 - 06/2013
2	spartalizumabIBA 01/2024 - 01/2022
2	Glycoproteins (Glycoprotein)IBA 12/2023 - 01/2021
2	VaccinesIBA 11/2022 - 01/2017
2	HLA-A*02:01 antigenIBA 10/2022 - 08/2010
2	tremelimumabIBA 01/2022 - 10/2021
2	durvalumabIBA 01/2022 - 10/2021
2	LY3022855IBA 10/2021 - 01/2021
2	Arginine (L-Arginine)FDA Link 01/2021 - 04/2013
2	EnzymesIBA 01/2021 - 04/2013
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2020
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021 - 12/2014
2	talimogene laherparepvecIBA 06/2020 - 10/2017
2	Melphalan (Alkeran)FDA LinkGeneric 01/2020 - 04/2019
2	VemurafenibIBA 10/2019 - 07/2015
2	Peptides (Polypeptides)IBA 07/2019 - 04/2011
2	HLA Antigens (Human Leukocyte Antigens)IBA 07/2019 - 08/2010
2	Dasatinib (BMS 354825)FDA Link 06/2019 - 06/2017
2	nilotinib FDA Link 06/2019 - 05/2015
2	Tyrosine Kinase InhibitorsIBA 06/2019 - 05/2015
2	PLX51107IBA 01/2019 - 01/2019
2	ontuxizumabIBA 01/2018 - 03/2015
2	Gemcitabine FDA Link 11/2015 - 01/2015
2	Immunoglobulins (Immunoglobulin)IBA 06/2015 - 06/2015
2	Temozolomide (Temodar)FDA LinkGeneric 06/2015 - 06/2014
2	Carboplatin (JM8)FDA LinkGeneric 04/2015 - 06/2012
2	PlatinumIBA 04/2015 - 12/2009
2	Alkaline PhosphataseIBA 04/2015 - 12/2011
2	CTLA-4 AntigenIBA 01/2015 - 01/2014
2	GTP-Binding Proteins (G-Protein)IBA 08/2014 - 07/2012
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2012 - 11/2010
2	MitogensIBA 07/2012 - 09/2011
2	Cisplatin (Platino)FDA LinkGeneric 06/2012 - 04/2011

Therapy/Procedure

64	Therapeutics 01/2024 - 12/2006
20	Immunotherapy 08/2023 - 06/2013
12	Drug Therapy (Chemotherapy) 12/2022 - 06/2013
7	Radiotherapy 01/2023 - 06/2010
3	Aftercare (After-Treatment) 02/2023 - 04/2014
2	Secondary Prevention 01/2020 - 01/2018
2	Neoadjuvant Therapy 04/2019 - 11/2015
2	Drug Tapering 01/2019 - 01/2009
2	Investigational Therapies (Experimental Therapy) 01/2018 - 11/2013